During mitosis, DNA topoisomerase II (TOP2) is required for sister chromatid separation. When TOP2 activity is inhibited, a decatenation checkpoint is activated by entangled chromatin. However, the functions of TOP2 in oocyte meiosis, particularly for homologous chromosome segregation during meiosis I, have not been investigated. In addition, it remains unknown if TOP2 inhibition activates a decatenation checkpoint at the G2/M transition in oocytes. In this study, we used mouse oocytes and specific inhibitors of TOP2 to investigate the role of TOP2 in meiosis. Our results indicated that an effective decatenation checkpoint did not exist in fully grown oocytes, as oocytes underwent the G2/M transition and reinitiated meiosis even when TOP2 activity was inhibited. However, oocytes treated with ICRF-193 had severe defects in chromosome condensation and homologous chromosome separation. Furthermore, condensed chromosomes failed to maintain their normal configurations in matured oocytes that were treated with ICRF-193. However, sister chromatid separation and subsequent chromosome decondensation during the exit from meiosis were not blocked by TOP2 inhibitors. These results indicated that TOP2 had a specific, crucial function in meiosis I. Thus, we identified important functions of TOP2 during oocyte maturation and provided novel insights into the decatenation checkpoint during meiosis.
INTRODUCTION
DNA topoisomerase II (TOP2) is an enzyme that resolves DNA topological problems by introducing transient doublestrand breaks (DSBs) [1] . TOP2 activity introduces a DSB, passes an unbroken strand through this transient break, and then reseals this break [1] . TOP2 poisons, such as etoposide (VP-16), teniposide, and doxorubicin, inhibit the religation step [1] , thereby generating large numbers of DSBs and activating DNA damage checkpoints [2, 3] . In contrast, TOP2 catalytic inhibitors, such as ICRF-187 and ICRF-193, inhibit the ATPase activity of TOP2 before the formation of DSBs and trigger the activation of a decatenation checkpoint [2, 4, 5] , which results in G2-phase arrest until chromosomes are properly disentangled. The delay in the G2/M transition induced by ICRF-193 is independent of the kinase activities of ATM, CHK1, and CHK2 [4] , all of which are required for DNA damage checkpoints. However, whether there is a decatenation checkpoint in meiosis and how it is regulated remain unknown.
TOP2 is also considered to play key roles in DNA replication, chromosome segregation, chromosome structure maintenance, and transcription. Studies with Drosophila S2 cells have shown that TOP2 was crucial for sister chromatid separation during mitosis [6, 7] and that these cells failed to establish amphitelic kinetochore attachments in the absence of TOP2 [7] . Studies with mammalian cells have obtained similar results in that TOP2 had an important function at the centromeric region [8] and was crucial for chromosome structure maintenance and chromosome condensation [9, 10] . Whether TOP2 has similar or different functions during meiosis, particularly during oocyte maturation, remains unclear.
TOP2 is also an important chemotherapy target. As examples, VP-16 and doxorubicin that inhibit the DNA ligase activity of TOP2, and thus create DNA DSBs in the genome, are widely used to kill tumor cells in cancer patients [11] . However, these drugs are highly toxic and have notable side effects, such as causing female infertility. In both female cancer patients and experimental animals, VP-16 and doxorubicin cause oocyte death and premature ovarian failure [12, 13] . Therefore, to better understand and find means to overcome these side effects of TOP2-targeting drugs, there is an urgent need to investigate the detailed functions of TOP2 in oocyte meiosis.
In this study, we investigated TOP2 localizations and functions during the meiotic maturation of mouse oocytes. Our results are the first to indicate that, unlike somatic cells, meiotic oocytes do not have a functional decatenation checkpoint. TOP2 activity was dispensable for oocyte meiotic resumption, but it was essential for meiotic chromosome condensation and separation.
MATERIALS AND METHODS

Oocyte Harvesting and Culture
Twenty-one day-old ICR mice were obtained from the Zhejiang Academy of Medical Science. Mice were injected with 5 IU of equine chorionic gonadotropin (eCG) (Ningbo Sansheng Pharmaceutical Co., Ltd.) and humanely euthanized 44 h later. Oocytes at the germinal vesicle (GV) stage were harvested in M2 medium (M7167; Sigma-Aldrich) and thoroughly washed. Oocytes were cultured in mini-drops of M16 medium (M7292; SigmaAldrich) covered with mineral oil (M5310; Sigma-Aldrich) at 378C in a 5% CO 2 atmosphere.
To harvest oocytes at the metaphase II (MII) stage, mice were intraperitoneally injected with eCG and then with human chorionic gonadotropin (hCG) (Ningbo Sansheng Pharmaceutical Company) 44 h later. Cumulus-enclosed MII oocytes were obtained by tearing the ampullae of oviducts at 16 h after hCG injection. To denude oocytes, cumulus cells were removed by a brief exposure to 300 IU/ml of hyaluronidase (H4272; SigmaAldrich). All animal care and experiments were conducted in accordance with the Animal Research Committee guidelines of Zhejiang University, China.
Parthenogenetic Activation of Oocytes
Denuded oocytes at the MII stage were harvested 12 h after hCG injection, and treated with ICRF-193 (20 lM; I4659; Sigma-Aldrich), VP-16 (20 lg/ml; E1383; Sigma-Aldrich) or bleomycin (BLM) (10 lM; B2434; Sigma-Aldrich) for 4 h before activation. Then, after treatment with 5 lM calcium ionophore A23187 (C7522; Sigma-Aldrich) in M2 medium for 5 min, oocytes were cultured in M16 medium containing 10 lg/ml of cycloheximide (01810; Sigma-Aldrich) covered with mineral oil at 378C in a 5% CO 2 atmosphere. After 2 and 8 h, second polar body emission and pronuclear formation were examined, respectively.
In Vitro Fertilization
For in vitro fertilization, the cauda epididymis of an adult male mouse was placed in 200 ll of M16 medium with 2.5 mM taurine (T0625; Sigma-Aldrich) and squeezed to let the spermatozoa swim out. Then, spermatozoa were cultured in M16 medium with 2.5 mM taurine for 1 h at 378C in a 5% CO 2 atmosphere.
When spermatozoa were cultured, the zona pellucida (ZP) was removed from MII oocytes that had been treated for 4 h with ICRF-193 (20 lM), VP-16 (20 lg/ml), or BLM (10 lM) by a short exposure to acidified M2 medium (pH 2.5). Then, the capacitated spermatozoa were added to a drop of M16 medium that contained 20-30 MII oocytes. The final concentration of spermatozoa was 5 3 10 5 /ml. Pronuclei were observed after 8 h of culture.
Immunofluorescent Microscopy for Mouse Oocytes
ZP-free oocytes were fixed in PBS (137 mM sodium chloride, 2.7 mM potassium chloride, 10 mM dibasic sodium phosphate, 2 mM potassium phosphate monobasic in H 2 O)-buffered 4% paraformaldehyde (P6148; SigmaAldrich) for at least 30 min at room temperature. After blocking with 1% BSA (AD0023; Sangon Biotech Co., Ltd.) in PBS, oocytes were incubated for 1 h at room temperature with primary antibodies diluted in blocking solution. After three washes in PBS, oocytes were labeled with secondary antibodies for 45 min, and then counterstained with 4,6-diamidino-2-phenylindole (DAPI) (D9542; Sigma-Aldrich) or propidium iodide (PI) (P21493; Life Technologies Corp.) for 10 min. Oocytes were mounted on glass slides using SlowFade Gold Antifade Reagent (S36936; Life Technologies) and examined with a confocal laser scanning microscope (Zeiss LSM 710; Carl Zeiss AG).
Primary antibodies were anti-TOP2B (1:100 dilution; 3747-1; Epitomics; it can recognize both isoforms of TOP2 according to our Western blot results), anti-phospho-histone H2A.X (Ser-139) (1:100 dilution; 2577; Cell Signaling Technology), anti-phospho-CHK1 (Ser-345) (1:100 dilution; 2348; Cell Signaling Technology), anti-phospho-CHK2 (Thr-68) (1:100 dilution; 2661; Cell Signaling Technology), and fluorescein isothiocyanate (FITC)-labeled anti-a-tubulin and anti-phospho-ATM (Ser-1981) (1:100 dilution; ab36810; Abcam). The secondary antibody was Cy3-conjugated goat anti-rabbit IgG (1:400 dilution; 111-165-003; Jackson ImmunoResearch Laboratories).
Chromosome Spreading and Immunofluorescence
The method of chromosome spreading was modified slightly according to Hodges and Hunt [14] . For chromosome spreading, ZP-free oocytes were fixed in a solution containing 1% paraformaldehyde, 0.15% Triton X-100 (TB0198; Sangon, Biotech), and 3 mM dithiothreitol (43815; Sigma-Aldrich) [14] on glass slides for 30 min. After fixation, slides were air dried. To perform immunofluorescence analysis of dispersed chromosomes, slides were blocked with 1% BSA and then incubated for 1 hour with primary antibodies. After rinsing three times, slides were incubated with secondary antibodies for 45 min, followed by DAPI or PI staining. Slides were then mounted with antifade reagent and examined with a confocal laser scanning microscope (Zeiss LSM 710).
Primary antibodies were anti-TOP2B, anti-phospho-histone H2A.X (Ser-139), CREST antiserum (1:100 dilution; 90C-CS1058; Fitzgerald Industries International), anti-histone H3 (tri-methyl K9) (1:100 dilution; ab1773; Abcam), anti-survivin (1:100 dilution; 71G4B7; Cell Signaling Technology), anti-phospho-histone H3 (Ser-10) (1:100 dilution; 9701; Cell Signaling Technology), and anti-BUB3 (1:100 dilution; sc-28258; Santa Cruz Biotechnology). Secondary antibodies were Cy3-conjugated goat anti-rabbit IgG, FITC-conjugated donkey anti-human IgG (1:400 dilution; 709-545-149; Jackson ImmunoResearch Laboratories), and Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:400 dilution; 111-545-045; Jackson ImmunoResearch Laboratories).
Western Blot Analysis
Fully grown GV oocytes were cultured in M16 medium containing BLM, VP-16, or ICRF-193 for 12 h. To maintain oocytes at the GV stage, 3-isobutyl-1-methylxanthine (IBMX) (I7018; Sigma-Aldrich) was added at a final concentration of 250 lM. After culture, oocytes were lysed with SDS sample buffer (200 oocytes per sample) and heated for 5 min at 958C. Total oocyte proteins were separated by SDS-PAGE and electrophoretically transferred to polyvinylidene fluoride membranes (Millipore Corp.), followed by blocking in TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20 [T0777; Sangon Biotech], pH = 7.5) containing 5% skimmed milk (Becton, Dickinson and Company) for 30 min. After probing with primary antibodies, the membranes were washed in TBST and incubated with a horseradish peroxidase (HRP)-linked secondary antibody for 1 hour, followed by thorough washing. Finally, bound antibodies were detected using SuperSignal West Femto maximum sensitivity substrate (34095; Thermo Fisher Scientific Inc.).
Primary antibodies were anti-phospho-histone H2A.X (Ser-139) (1:1000 dilution), anti-phospho-CHK1 (Ser-345) (1:1000 dilution), and anti-ERK1/2 (1:1000 dilution; sc-292838; Santa Cruz Biotechnology). The secondary antibody was HRP-conjugated anti-rabbit IgG (1:400 dilution; 111-035-003; Jackson ImmunoResearch Laboratories).
RESULTS
TOP2 Localization During Mouse Oocyte Maturation
To determine TOP2 localization during oocyte meiosis, we harvested mouse oocytes that had been cultured in vitro for 0, 4, 6, 8, 10, and 12 h; these times corresponded to, respectively, the GV, GV breakdown (GVBD), prometaphase I, metaphase I (MI), anaphase I, and MII stages. Immunofluorescent signals (Fig. 1A) showed that TOP2 was distinctly localized in GVs at the GV stage. As soon as GVBD occurred, TOP2 began to concentrate in chromosomes. At 8 h after culture began, the time at which chromosomes were condensed and the MI spindle was completely assembled, TOP2 was significantly localized on chromosomes and remained there until the MII stage.
To determine the precise localization of TOP2 on chromosomes, we did chromosome-spreading experiments using oocytes at MI stage (Fig. 1B) . Consistent with our observations for whole oocytes, TOP2 was primarily localized in a region adjacent to the centromeres, which were identified by CREST staining (Fig. 1B) . Weak but clear TOP2 signals in a linear distribution were also detected along chromosome arms.
TOP2 Activity Is Dispensable for Meiotic Resumption, but Is Required for Chromosome Separation During Meiosis I
In somatic cells, a decatenation checkpoint is activated when chromosomes are entangled prior to condensation and results in delaying the G2/M transition. This checkpoint can be experimentally activated by inhibiting TOP2 activity, because physiologically TOP2 is the enzyme that decatenates entangled DNAs by making DSBs to release helix stress and then reseals these breaks. The decatenation checkpoint is distinct from the DNA damage checkpoint and other G2/M transition checkpoints [2] . Because TOP2 was distinctly detected in the GVs of LI ET AL.
G2-arrested oocytes and on the centromeres of meiotic chromosomes, we also investigated if there was a decatenation checkpoint during the G2/M transition of oocyte meiosis and if TOP2 played a role in this event.
Three drugs were used in these and subsequent experiments.
(1) ICRF-193 was used as a TOP2 inhibitor, as it inhibits the DNA endonuclease activity of TOP2. ICRF-193 reportedly activates the decatenation checkpoint without causing DNA FIG. 1. TOP2 localization and function during oocyte maturation. A) TOP2 localization during oocyte meiotic maturation. Oocytes were harvested after culture for 0, 4, 6, 8, 10, and 12 h; these times corresponded to, respectively, the GV, GVBD, pro-MI, MI, anaphase I, and MII stages. Oocytes were stained with anti-TOP2 (red), anti-a-tubulin (green), and DAPI (blue). Bar ¼ 50 lm. B) Localization of TOP2 on chromosomes. Chromosome spreads were made using MI oocytes and double stained with anti-TOP2 (red) and anti-CREST (green). DNA was labeled with DAPI (blue). C) TOP2 inhibition does not affect GVBD, but does prevent PB1 emission. GV oocytes were harvested and treated overnight with either IBMX (250 lM), IBMX TOP2 AND OOCYTE MEIOSIS damage in somatic cells. (2) VP-16 was used as a ''half inhibitor'' of TOP2, as it selectively inhibits the DNA ligase activity of TOP2, but not its endonuclease activity. Thus, this drug causes DNA DSB accumulation and thereby activates DNA damage checkpoints. (3) BLM is a drug used in chemotherapy that strongly activates DNA damage checkpoint by creating DNA DSBs unrelated to TOP2 activity.
We harvested fully grown mouse GV oocytes and treated them overnight with ICRF-193, VP-16, or BLM. IBMX was also added to the culture medium to maintain GV arrest. After overnight culture, oocytes were released by removing IBMX. These control oocytes underwent spontaneous GVBD (G2/M transition during meiosis) within 2-3 h after they were released from IBMX and emitted their first polar bodies (PB1s) within 10-12 h (Fig. 1C) . Surprisingly, oocytes underwent GVBD normally in the presence of ICRF-193, which implied that a decatenation checkpoint did not exist in meiotic oocytes. In contrast, GVBD was blocked by VP-16 or BLM treatment (Fig. 1, C and D) . We postulated that this was due to activation of a DNA damage checkpoint rather than a decatenation checkpoint.
To demonstrate that ICRF-193 used in our experiments did inhibit TOP2 activity, we treated HeLa cells with this drug at the same concentration used for oocyte culture. Nocodazole was also added to the culture medium to prevent mitotic cells from entering the G1 phase. Immunostaining for phosphohistone H3 (Ser-10), a marker of mitotic chromosomes, indicated that ICRF-193 efficiently blocked the G2/M transition in HeLa cells and induced the activation of decatenation checkpoint, as expected (Fig. 1E) .
In addition, when cultured for 12 h, control oocytes extruded PB1s, whereas most oocytes treated with ICRF-193 did not, which suggested deficient segregation of homologous chromosomes (Fig. 1C) . Although most VP-16-or BLMtreated oocytes failed to undergo GVBD, a small fraction of oocytes that escaped GV arrest did not release PB1s (Fig. 1C) .
Based on these results, we concluded that a decatenation checkpoint was absent in oocytes; TOP2 was dispensable for meiotic resumption, but was required for chromosome separation during oocyte meiotic maturation.
TOP2 Inhibition by ICRF-193 Does Not Activate a DNA Damage Checkpoint in Oocytes
To exclude the possibility that the effect of ICRF-193 on oocytes was caused by creating DNA DSBs, we used immunofluorescence analysis to detect proteins related to a DNA damage checkpoint. GV oocytes were treated overnight with ICRF-193, VP-16, or BLM (for reasons previously described). Phospho-H2A.X (Ser-139) was used as a marker to detect DNA damage [15] . These results indicated that oocytes treated with VP-16 or BLM had increased levels of phospho-H2A.X (Ser-139), whereas ICRF-193 treatment did not cause these changes (Fig. 2A) . This indicated that VP-16 and BLM indeed caused DSB accumulation in oocytes, but that ICRF-193 did not.
As an initial step, establishing a DNA damage checkpoint requires ATM autophosphorylation [16] . As shown in Fig. 2A , the phospho-ATM (Ser-1981) level was low in control and ICRF-193-treated oocytes, but was strongly enhanced by VP-16 or BLM. The phosphorylation of CHK1 (Ser-345) and CHK2 (Thr-68), two major protein kinases activated by ATM in response to DNA damage [17, 18] , was notably induced in oocytes that were treated with VP-16 or BLM, but not with ICRF-193 ( Fig. 2A) . Western blot analysis of oocyte proteins gave the same results; H2A.X and CHK1 were phosphorylated only when oocytes were treated with VP-16 or BLM (Fig. 2C) .
Then, we examined for DNA DSBs on condensed chromosomes after GVBD. Oocytes were treated with ICRF-193, VP-16, or BLM. Oocytes were then allowed to develop to MI and were harvested for chromosome-spreading experiments. Strong phospho-H2A.X (Ser-139) signals were detected on chromosomes from VP-16-or BLM-treated oocytes, but not on chromosomes from control or ICRF-193-treated oocytes (Fig. 2B) . Based on these results, we concluded that TOP2 inhibition by ICRF-193 did not result in DNA damage that activated a DNA damage checkpoint. The different effects of VP-16 and ICRF-193 on oocyte meiotic resumption were likely due to VP-16's ability to activate a DNA damage checkpoint, as with BLM.
TOP2 Inhibition Causes Meiotic Chromosome Abnormalities
Because oocyte meiosis was arrested at MI or earlier when TOP2 activity was inhibited by ICRF-193, we investigated the morphological details of this defect. When examined at 10 h after GVBD, ICRF-193-and VP-16-treated oocytes had severe chromosome segregation defects, forming thin, threadlike chromosome bridges under spindle microtubule tension (Fig.  3A) . In addition, some chromosomes failed to align at the equator and were pulled to the spindle poles.
For BLM-treated oocytes, a small fraction released PB1s and developed to the MII stage; however, spindles were abnormal and multiple spindle poles and several additional microtubule organizing centers (MTOCs) were observed in the cytoplasm. Also, chromosomes were not properly aligned at the equator. However, in many BLM-treated oocytes, these defects were more severe, as chromosomes were fragmented and no meiotic spindles had assembled (Fig. 3A) . Not surprisingly, PB1s were not released by these oocytes. However, entangled, unseparated chromosomes were not observed in BLM-treated oocytes.
The results obtained with ICRF-193-and VP-16-treated oocytes indicated that both the endonuclease and ligase activities of TOP2 were required for homologous chromosome separation during oocyte meiosis I. Surprisingly, when oocytes were treated with VP-16 or ICRF-193 overnight and then released, the TOP2 signal on chromosomes had remarkably reduced (Fig. 3B) . Western blotting of TOP2 indicated that VP-16 or ICRF-193 treatment caused a significant decrease of TOP2 protein level in both oocytes and HeLa cells (Fig. 3C) . Although BLM treatment also led to reduction of TOP2, this decrease was much less when compared with VP-16 or ICRF-193 treatment. These results indicated that TOP2 inhibition also directly or indirectly affected TOP2 stability.
TOP2 Activity Is Required for Chromosome Condensation During Oocyte Maturation
We performed chromosome-spreading experiments to further investigate TOP2 functions in chromosome condensation. In this experiment the oocytes were treated with ICRF-193 or VP-16 for 8 h, but without IBMX, therefore allowing GVBD to occur normally. As shown in Figure 4A , after ICRF-193 treatment, chromatin failed to become disentangled and condensed to form individual chromosomes, although a mass of thin chromatin strands was formed, which was consistent with our observations of whole oocytes with confocal microscopy. In addition, TOP2 was still detected on chromosomes after this treatment, not localized on centromeres, but diffusedly distributed on the chromatin mass.
CREST staining indicated that centromeres were still present, but had lost their colocalization with TOP2. This aberrant centromere localization was further confirmed using immunostaining for another kinetochore marker, BUB3 (Fig.   FIG. 4 . Effects of TOP2 inhibition on chromosome condensation during oocyte maturation. A) GV oocytes were cultured for 8 h in the presence of ICRF-193 (20 lM) or VP-16 (20 lg/ml) before chromosome spreads were made. Chromosomes were stained with anti-TOP2 or anti-trimethylated histone H3K9 (red). Centromeric regions were marked by anti-CREST (green). DNA was stained with DAPI (blue). B) BUB3 distribution is disrupted in oocytes cultured with ICRF-193 (20 lM). Chromosomes were stained with anti-BUB3 (green) and PI (red). C and D) Chromosomes were stained with anti-phospho-histone H3 (C) or anti-survivin (D) (green). DNA was stained with PI (red). Bars ¼ 50 lm.
3
were fixed 12 h later and stained with anti-TOP2 (red), anti-a-tubulin (green), and DAPI (blue). Bar ¼ 50 lm. C) Western blotting results showing the TOP2 protein levels in oocytes and HeLa cells with or without TOP2 inhibitor treatments. GV oocytes were treated as in B, and then were lysed for Western blotting.
TOP2 AND OOCYTE MEIOSIS 4B
). VP-16-treated oocytes had some defects similar to those in ICRF-193-treated oocytes, except that some chromosomes were disentangled and had separated from the chromatin mass (Fig. 4A) . These results indicated that TOP2 was required for chromosome condensation and proper localizations of important chromosomal proteins during oocyte maturation. In addition, TOP2 endonuclease activity was more important for DNA disentanglement, whereas both its endonuclease and ligase activities were required for chromosome condensation during oocyte meiosis.
Because ICRF-193 and VP-16 treatments caused dramatic changes in chromosome configurations, we studied the effects of TOP2 inhibition on histone modifications. We examined two forms of histone H3: phosphorylated H3 at Ser-10 and trimethylated H3 at Lys-9 (H3K9). Phosphorylation at Ser-10 is crucial for chromosome condensation. However, in our experiments, the signals of phospho-histone H3 staining were not different between control and ICRF-193-treated oocytes (Fig. 4C ). H3K9 plays a central role in transcription regulation. We found that trimethyl-H3K9 was primarily localized on centromeres, with weaker signals on chromosome arms. In ICRF-193-and VP-16-treated oocytes, the trimethyl-H3K9 levels were not affected, but the H3K9 staining appeared to have more intense accumulation; also, H3K9 localization was significantly dissociated with centromeres in VP-16-treated oocytes.
Because we had observed deficiencies in chromosome condensation after TOP2 inhibition, we next investigated if the localizations of some functional proteins involved in chromosome behavior and segregation were also affected. Survivin is an inhibitor of apoptosis that was recently shown to have crucial functions in spindle organization [19] and chromosome alignment [20] . As shown in Fig. 4D , survivin was preferentially localized on centromeric regions, but was also distributed along chromosome arms. When oocytes were treated with ICRF-193, VP-16, or BLM, survivin remained localized on chromosomes, but its distribution became dispersed in conjunction with disruption of the centromeric structures (Fig. 4D ).
TOP2 Activity Is Required for Maintaining the Chromosome Configuration in Mature Oocytes
Our results thus far indicated that TOP2 played crucial roles in meiosis I of mammalian oocytes. In the following experiments, we studied the functions of TOP2 in meiosis II of mature ovulated oocytes.
First, we investigated TOP2 function for maintaining chromosome structures during MII arrest. MII oocytes were treated with ICRF-193, VP-16, or BLM for 6 h before chromosome spreading. After ICRF-193 or VP-16 treatment, chromosomes were decondensed and became loose (increase of chromosome arm broadness). However, BLM treatment did not cause these changes of chromosome configurations. In addition, normal TOP2 and BUB3 distributions were disrupted (Fig. 5A) . Because histone H3 phosphorylation at Ser-10 is a prerequisite for chromosome condensation, we also examined if TOP2 inhibition (ICRF-193 and VP-16) or DNA damage (VP-16 and BLM) affected the phospho-histone H3 levels at the MII stage. As shown in Figure 5A , the signals of phosphohistone H3 remained unchanged after treatment with ICRF-193, VP-16, or BLM, although there was dramatic chromosome decondensation after TOP2 inhibition. These results indicated that TOP2 activity was required not only for chromosome condensation during meiotic resumption, but also for maintaining the condensed chromosome configuration during MII arrest.
TOP2 Activity Is Not Required for Chromosome Decondensation After Egg Activation
Next, we investigated if TOP2 activity was also required for sister chromatid separation during meiosis II, as it was for homologous chromosome separation during meiosis I. MII oocytes were pretreated in culture with ICRF-193 for 4 h, and were then activated by either fertilization or parthenogenetic activation. PB2 emission and pronuclear formation were examined after 2 and 8 h, respectively.
In zygotes, parthenogenetically activated oocytes, and 2-cell embryos, TOP2 was clearly localized in nuclei (Fig. 5B) . Interestingly, ICRF-193 and VP-16 did not block either PB2 emission or pronuclear formation (Fig. 5C ), although they did cause chromosome decondensation in MII oocytes (Fig. 5A) . However, sister chromatids were not properly separated in parthenogenetically activated ICRF-193-or VP-16-treated MII oocytes (Fig. 5D ). In these oocytes, some chromosomes remained at the middle plates when other chromosomes had already moved to the spindle poles at anaphase II. We also observed that in some oocytes, the separated chromosomes were still connected by thin threads of undecatenated chromatin. These results suggested that when TOP2 was inhibited during meiosis II, sister chromatids were forcibly torn apart.
DISCUSSION
The Decatenation Checkpoint and DNA Damage Checkpoint During Oocyte Meiosis A decatenation checkpoint has been observed in many mammalian cell types during mitosis [2] [3] [4] [21] [22] [23] [24] . However, the lack of a decatenation checkpoint in stem and progenitor cells has also been reported [22] . No previous study has been done to test for a decatenation checkpoint in mammalian oocytes. In the presence of TOP2 inhibitors, we did not observe G2/M arrest during mouse oocyte maturation, which implied that there was no decatenation checkpoint in oocytes. However, Bright-field images were taken at 4 h after activation. For confocal microscopy, activated eggs were fixed 2 h after culture and costained with anti-a-tubulin (green) and DAPI (blue). Data are representative of three independent experiments (6SEM). Bar ¼ 50 lm. E) Summary of TOP2 localizations and functions in mouse oocytes. In fully grown GV oocytes, TOP2 localizes in GVs. After GVBD, TOP2 becomes concentrated in the centromeric regions of condensed chromosomes. After fertilization, TOP2 relocalizes to the pronuclei of zygotes and the nuclei of two-cell embryos. TOP2 inhibition at the GV stage does not block GVBD, but does prevent chromosome condensation and PB1 emission. In addition, TOP2 inhibition in mature MII oocytes does not affect fertilization-stimulated PB2 emission and pronuclear formation. However, maternally inherited TOP2 is required for chromosome separation and nuclear division in early embryos. TOP2 localization is shown in red. Microtubules are highlighted in green.
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what mechanism was responsible for this deficiency remains unknown.
It has been reported that embryonic stem cells have distinct nuclei and chromatin structures as compared to other cells [25] [26] [27] , which may be responsible for this lack of a decatenation checkpoint. Similarly, mammalian oocytes at the GV stage also have unique chromatin structures [28] , which may contribute to this ineffective checkpoint in oocytes. A recent study has shown that TOP2 phosphorylation on serine 1524 is essential for activating a decatenation checkpoint induced by ICRF-193 [29] . This resulted from exposing phosphorylated TOP2 (Ser-1524) after ICRF-193 treatment and recruiting MDC1 (an important checkpoint protein) to chromatin. Therefore, an inability to phosphorylate TOP2 (Ser-1524) in GV-stage oocyte might have caused the ineffective decatenation checkpoint.
Role of TOP2 in Chromosome Condensation and Separation
We treated oocytes with ICRF-193, a TOP2 catalytic inhibitor, and found that meiotic chromosomes could not condense (during meiosis I) or failed to maintain their condensed configuration (at MII). However, a role for TOP2 in chromosome condensation remains unclear. We tested for the levels of histone H3 modifications, including phosphorylation at Ser-10 and trimethylation at Lys-9, but did not observe any dramatic differences. Studies on mitosis have revealed that TOP2 is included in condensing [1, [30] [31] [32] [33] . However, its functions in meiotic chromosomes will require further investigations.
Another observation in our experiments was the aberrant spindles in ICRF-193-, VP-16-, or BLM-treated oocytes (Fig.  3A) . We propose that the aberrant spindles were caused by defects in chromosome condensation. There are currently two models for spindle assembly. One is the search-and-capture model, which suggests that microtubules emanate from MTOCs and search for kinetochores. Once bound to a kinetochore, they become stabilized [34, 35] . A second model is self-organization, in which microtubules are nucleated near each chromosome and spontaneously assemble into spindlelike structures [36] . In mice and Xenopus laevis oocytes, the assembly of meiosis I spindles is centriole independent [37] . Our experimental evidence suggests that these two models are not mutually exclusive and that both might contribute to the correct assembly of spindles.
When chromosome condensation was blocked by ICRF-193, TOP2 and other proteins failed to localize to centromeric regions, and thus impaired microtubule attachment. According to the search-and-capture model, this is a key step in spindle formation. As a result, the MTOC could not capture chromosomes and spindle assemblies failed in these oocytes. Also from our experiments, when oocytes were cultured with VP-16 or BLM, chromosomes broke into fragments because these two drugs generate massive DSBs in the oocyte genome. We found that multipolar spindles were formed near these chromosome fragments, which provides evidence for the selforganization model.
TOP2 Evolutionary Conservation and Redundancy
Both the biochemical features and physiological functions of TOP2 have been highly conserved during evolution. Although the function of TOP2 in mammalian oocytes has not been previously investigated, its role in yeast meiosis has been reported. In a heat-sensitive top2 mutant of Schizosaccharomyces pombe, DNA replication, prophase morphology, and dynamics of the linear elements are normal during the early stages of meiosis. However, this mutation results in a loss of chromatin condensation shortly before meiosis I, failure of sister chromatid separation, and nonregulatory arrest [38] .
Vertebrates have two TOP2 isoforms, TOP2a and TOP2b, which are encoded for by different genes (Top2a and Top2b, respectively). They have similar primary structures and have nearly identical catalytic properties in vitro. Commonly used TOP2 inhibitors inhibit the enzymatic activities of both TOP2a and TOP2b. Using small interfering RNAs that selectively targeted Top2a or Top2b, Sakaguchi and Kikuchi investigated the individual cellular roles of these TOP2 isoforms in HeLa cells [39] . They showed that chromosomes were condensed when TOP2a was nearly absent. Although some lagging chromosomes were observed, these cells still managed to segregate at anaphase. In contrast, TOP2b was not required for normal mitotic events. Double-knockdown experiments revealed that TOP2b could partially substitute for TOP2a for chromosome condensation and segregation. Therefore, TOP2a may play a major role in oocyte meiosis or, possibly, TOP2a and TOP2b are highly redundant for this crucial life event. This important question should be answered when a Top2a/b floxed mouse strain becomes available.
Taking all of our results together, we investigated TOP2 localization and function during oocyte maturation, egg activation, and early embryonic development both in vitro and in vivo. These results are summarized in Figure 5E . We found that TOP2 played a key role in chromosome condensation and separation during oocyte meiosis. This was comparable to TOP2's function during mitosis. However, unlike findings with somatic cells, our results also indicated that TOP2 was dispensable for the G2/M transition in oocytes and in early embryos.
